Literature DB >> 17065456

Alexander disease-associated glial fibrillary acidic protein mutations in mice induce Rosenthal fiber formation and a white matter stress response.

Tracy L Hagemann1, Jolien X Connor, Albee Messing.   

Abstract

Mutations in the gene for the astrocyte specific intermediate filament, glial fibrillary acidic protein (GFAP), cause the rare leukodystrophy Alexander disease (AxD). To study the pathology of this primary astrocyte defect, we have generated knock-in mice with missense mutations homologous to those found in humans. In this report, we show that mice with GFAP-R76H and -R236H mutations develop Rosenthal fibers, the hallmark protein aggregates observed in astrocytes in AxD, in the hippocampus, corpus callosum, olfactory bulbs, subpial, and periventricular regions. Astrocytes in these areas appear reactive and total GFAP expression is elevated. Although general white matter architecture and myelination appear normal, when crossed with an antioxidant response element reporter line, the mutant mice show a distinct pattern of reporter-gene induction that is especially prominent in the corpus callosum, and histochemical staining reveals accumulation of iron in the same region. The mutant mice have a normal lifespan and show no overt behavioral defects, but are more susceptible to kainate-induced seizures. Although these mice demonstrate increased GFAP expression by themselves, further elevation of GFAP via crosses to GFAP transgenic animals leads to a shift in GFAP solubility, an increased stress response, and ultimately death. The mice do not display the full spectrum of pathology observed in human infantile AxD, but may more closely resemble the adult form of the disease. These studies provide formal proof linking GFAP mutations with Rosenthal fibers and oxidative stress, and correlate gliosis and GFAP protein levels to the severity of the disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17065456      PMCID: PMC6674663          DOI: 10.1523/JNEUROSCI.3260-06.2006

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  65 in total

1.  Drug screening to identify suppressors of GFAP expression.

Authors:  Woosung Cho; Michael Brenner; Noel Peters; Albee Messing
Journal:  Hum Mol Genet       Date:  2010-06-10       Impact factor: 6.150

2.  The impact of glial activation in the aging brain.

Authors:  Aileen M Lynch; Kevin J Murphy; Brian F Deighan; Julie-Ann O'Reilly; Yuri K Gun'ko; Thelma R Cowley; Rodrigo E Gonzalez-Reyes; Marina A Lynch
Journal:  Aging Dis       Date:  2010-09-04       Impact factor: 6.745

3.  Alexander disease mutant glial fibrillary acidic protein compromises glutamate transport in astrocytes.

Authors:  Rujin Tian; Xiaoping Wu; Tracy L Hagemann; Alexandre A Sosunov; Albee Messing; Guy M McKhann; James E Goldman
Journal:  J Neuropathol Exp Neurol       Date:  2010-04       Impact factor: 3.685

4.  Traumatically injured astrocytes release a proteomic signature modulated by STAT3-dependent cell survival.

Authors:  Jaclynn Levine; Eunice Kwon; Pablo Paez; Weihong Yan; Gregg Czerwieniec; Joseph A Loo; Michael V Sofroniew; Ina-Beate Wanner
Journal:  Glia       Date:  2015-12-19       Impact factor: 7.452

Review 5.  GFAP and its role in Alexander disease.

Authors:  Roy A Quinlan; Michael Brenner; James E Goldman; Albee Messing
Journal:  Exp Cell Res       Date:  2007-04-06       Impact factor: 3.905

6.  GFAP Mutations in Astrocytes Impair Oligodendrocyte Progenitor Proliferation and Myelination in an hiPSC Model of Alexander Disease.

Authors:  Li Li; E Tian; Xianwei Chen; Jianfei Chao; Jeremy Klein; Qiuhao Qu; Guihua Sun; Guoqiang Sun; Yanzhou Huang; Charles D Warden; Peng Ye; Lizhao Feng; Xinqiang Li; Qi Cui; Abdullah Sultan; Panagiotis Douvaras; Valentina Fossati; Neville E Sanjana; Arthur D Riggs; Yanhong Shi
Journal:  Cell Stem Cell       Date:  2018-08-02       Impact factor: 24.633

7.  Properties of astrocytes cultured from GFAP over-expressing and GFAP mutant mice.

Authors:  Woosung Cho; Albee Messing
Journal:  Exp Cell Res       Date:  2008-12-29       Impact factor: 3.905

8.  Astrocytic TDP-43 pathology in Alexander disease.

Authors:  Adam K Walker; Christine M LaPash Daniels; James E Goldman; John Q Trojanowski; Virginia M-Y Lee; Albee Messing
Journal:  J Neurosci       Date:  2014-05-07       Impact factor: 6.167

9.  Composition of Rosenthal Fibers, the Protein Aggregate Hallmark of Alexander Disease.

Authors:  Michael R Heaven; Daniel Flint; Shan M Randall; Alexander A Sosunov; Landon Wilson; Stephen Barnes; James E Goldman; David C Muddiman; Michael Brenner
Journal:  J Proteome Res       Date:  2016-06-02       Impact factor: 4.466

10.  Phenotypic conversions of "protoplasmic" to "reactive" astrocytes in Alexander disease.

Authors:  Alexander A Sosunov; Eileen Guilfoyle; Xiaoping Wu; Guy M McKhann; James E Goldman
Journal:  J Neurosci       Date:  2013-04-24       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.